Patents by Inventor Viswanathan RAMASAMY

Viswanathan RAMASAMY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetravalent dengue vaccine
    Patent number: 11945842
    Abstract: The invention provides a recombinant polypeptide comprising the EDIII domain of each of Dengue virus serotype DENV-1, DENV-2, DENV-3, and DENV-4 linked to the N-terminal of HBsAg.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: April 2, 2024
    Assignee: INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
    Inventors: Navin Khanna, Viswanathan Ramasamy
  • TETRAVALENT DENGUE VACCINE
    Publication number: 20210122787
    Abstract: The invention provides a recombinant polypeptide comprising the EDIII domain of each of Dengue virus serotype DENV-1, DENV-2, DENV-3, and DENV-4 linked to the N-terminal of HBsAg.
    Type: Application
    Filed: October 22, 2020
    Publication date: April 29, 2021
    Inventors: Navin KHANNA, Viswanathan RAMASAMY
  • Tetravalent dengue vaccine
    Patent number: 10815280
    Abstract: The invention provides a recombinant polypeptide comprising the EDIII domain of each of Dengue virus serotype DENV-1, DENV-2, DENV-3, and DENV-4 linked to the N-terminal of HBsAg.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: October 27, 2020
    Assignee: INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY
    Inventors: Navin Khanna, Viswanathan Ramasamy
  • TETRAVALENT DENGUE VACCINE
    Publication number: 20190194261
    Abstract: The invention provides a recombinant polypeptide comprising the EDIII domain of each of Dengue virus serotype DENV-1, DENV-2, DENV-3, and DENV-4 linked to the N-terminal of HBsAg.
    Type: Application
    Filed: December 6, 2018
    Publication date: June 27, 2019
    Inventors: Navin KHANNA, Viswanathan RAMASAMY
  • Tetravalent dengue vaccine
    Patent number: 10189877
    Abstract: The invention provides a recombinant polypeptide comprising the EDIII domain of each of Dengue virus serotype DENV-1, DENV-2, DENV-3, and DENV-4 linked to the N-terminal of HBsAg.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: January 29, 2019
    Assignee: International Centre for Genetic Engineering and Biotechnology
    Inventors: Navin Khanna, Viswanathan Ramasamy
  • VACCINE
    Publication number: 20170240601
    Abstract: The invention provides a recombinant polypeptide comprising the EDIII domain of each of Dengue virus serotype DENV-1, DENV-2, DENV-3, and DENV-4 linked to the N-terminal of HBsAg.
    Type: Application
    Filed: August 21, 2015
    Publication date: August 24, 2017
    Inventors: Navin KHANNA, Viswanathan RAMASAMY